Harshini Neelakantan

Harshini  Neelakantan

Company: Ridgeline Therapeutics

Job title: Executive Director, Research & Development


Correcting Dysregulated Fat Metabolism: Unraveling a Novel Approach to Reverse Obesity, NASH & Type 2 Diabetes 12:00 pm

Leveraging an oral small molecule therapeutic to sustainably modulate adipose tissue metabolism Targeting the root cause: preventing or reversing fatty liver disease and the progression to NASH Obesity, NASH, and T2D: interrogating animal studies and translation to the clinicRead more

day: Day 1 Stream 1 AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.